Healthcare

The report shows cash and cash equivalents of $2,000 at the end of the quarter, up from $1,000 at the start. Receipts from customers were nil, the same as the previous period, and interest income of $1,000 was the only other operating line item …

The release gave no reason for the split and no Nasdaq deficiency details, so the motive is unconfirmed. As general background, companies often use reverse splits to lift the share price above the USD 1.00 minimum bid that Nasdaq requires, yet a split does …

No catalyst has been identified in published coverage dated November 9 or November 10, 2026. That matters, since a move of 8.12% with no news is often just order imbalance in thin trading. As general background, pre-market falls in medical device names typically followEarningsmisses, …

No catalyst has been identified in published coverage dated November 9 or November 10, 2026. Recent published items include the naming of board chair Lingtao Kong as chief executive officer, and a completed securities offering of USD 2.8 million. Neither is dated to November …

Key HighlightsCo-Diagnostics (NASDAQ:CODX) leads with a 29.47% rise, quoted at USD 0.4130 pre-market on November 10, 2026 from a calculated prior close of USD 0.3190, and published coverage gives no catalyst.Harrow, Inc. (NASDAQ:HROW) has risen 15.13% to USD 31.63 after third-quarterRevenueof USD 99.3 million, …

Key HighlightsTempest Therapeutics (NASDAQ:TPST) is indicated at USD 0.4050, up 12.06% pre-market on November 10, 2026, with aMarket Capitalisationof USD 7.23 million and no catalyst identified in published coverage.PMV Pharmaceuticals (NASDAQ:PMVP) was quoted at USD 1.39, up 11.27%, with no catalyst identified and third-quarter …

Key HighlightsKaryopharm Therapeutics (NASDAQ:KPTI) is quoted at USD 0.0311, down 22.25% pre-market on November 10, 2026, after its November 2 Chapter 11 filing, withNasdaqtrading suspended from November 11.Jin Medical International (NASDAQ:ZJYL) is indicated at USD 3.25, down 17.7% from a calculated prior close of …